Paweł Mielnik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Paweł Mielnik has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Artur Bąk
Polish-Japanese Academy of Information Technology
1 shared publication Ewa Wiesik-Szewczyk
Department of Connective Tissue Diseases, Institute of Rheumatology, Warsaw, Poland
1 shared publicationHanna Chwalinska-Sadowska
Department of Connective Tissue Diseases, Institute of Rheumatology, Warsaw, Poland
1 shared publicationJakub Segen
Polish-Japanese Academy of Information Technology, Warsaw, Poland
1 shared publication- Kamil Wereszczyński
Silesian University of Technology
1 shared publication - Marcin Fojcik
Faculty of Engineering and Science, Sogn og Fjordane University College, Førde, Norway
1 shared publication
Latest Publications
- Open Access
- 25 June 2024
- Published by Polish Academy of Sciences Chancellery in International Journal of Electronics and Telecommunications
- Vol. 70 (2) , 271-276
Detection of human finger joints in ultrasound images: structure and optimization
Synovitis is the inflammation of a synovial membrane surrounding a joint. Its assessment is an important step in the diagnosis and treatment of rheumatoid arthritis. Joint detection is the first stage of an automated method of assessment of a degree of synovitis, from an Ultrasound (USG) image of a finger joint and its surrounding area. A joint detector consists of three parts: image preprocessing, feature extraction, and classification. Each part contains adjustable parameters that must be set experimentally to ensure the proper operation of the detector. Both the structure of a joint detector and a procedure for finding a near-optimal configuration of the adjustable parameters are described. The optimization process is based on two evaluation measures: Area Under the Receiver Operating Characteristic Curve (AUC) and False Positive Count (FPC). The optimization process decreases the number of pictures with multiple detections, which was the main point of works presented in this paper. This was achieved by increasing the number of components of the homogeneous mixed-SURF descriptor which has the greatest influence on the final result. Non-SURF descriptors achieve poorer classification results. Our research led to the creation of a better joint detector which could positively influence the final results of inflammation level classification.
- 25 June 2024
- Published by Polish Academy of Sciences Chancellery in International Journal of Electronics and Telecommunications
- Vol. 70 (2) , 271-276
Open AccessDetection of human finger joints in ultrasound images: structure and optimization
Synovitis is the inflammation of a synovial membrane surrounding a joint. Its assessment is an important step in the diagnosis and treatment of rheumatoid arthritis. Joint detection is the first stage of an automated method of assessment of a degree of synovitis, from an Ultrasound (USG) image of a finger joint and its surrounding area. A joint detector consists of three parts: image preprocessing, feature extraction, and classification. Each part contains adjustable parameters that must be set experimentally to ensure the proper operation of the detector. Both the structure of a joint detector and a procedure for finding a near-optimal configuration of the adjustable parameters are described. The optimization process is based on two evaluation measures: Area Under the Receiver Operating Characteristic Curve (AUC) and False Positive Count (FPC). The optimization process decreases the number of pictures with multiple detections, which was the main point of works presented in this paper. This was achieved by increasing the number of components of the homogeneous mixed-SURF descriptor which has the greatest influence on the final result. Non-SURF descriptors achieve poorer classification results. Our research led to the creation of a better joint detector which could positively influence the final results of inflammation level classification.
- 1 January 2014
- Published by Fundacja Pro Medicina in Journal of Health Policy & Outcomes Research
- No. 1/2014
Drug procurement cooperation (LIS) – Norwegian tender system to reduce cost of expensive medicines
- 1 January 2014
- Published by Fundacja Pro Medicina in Journal of Health Policy & Outcomes Research
- No. 1/2014
Drug procurement cooperation (LIS) – Norwegian tender system to reduce cost of expensive medicines
- Open Access
- 4 December 2010
- Published by Springer Nature in Rheumatology International
- Vol. 32 (3) , 639-643
Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity
Cytokines are implied in polymyositis/dermatomyositis (PM/DM) pathogenesis. Our aim was to evaluate the serum levels of interleukin-15 (IL-15), soluble receptors for IL-2 (sIL-2R) and TNF-alpha type 1 receptor (sTNF-R1) in PM/DM patients and their relation to disease activity and clinical symptoms. Thirty-eight patients who met definite or probable criteria of Bohan and Peter for DM/PM were included into the study. Results in patients with active (41 observations) and inactive disease (24 observations) were compared with control (15 subjects). The median level of IL-15 was 47.6 ± 170 pg/ml in active patients, 25.15 ± 240 pg/ml in inactive and 28.5 ± 28.89 pg/ml in controls. We demonstrated significant differences between active patients and controls in levels of IL-15 (0.016, 95%CI 1.39–57.1). The median level of sIL-2R was 314 ± 388, 235.3 ± 269 and 144.3 ± 152.9 pg/ml, and the median level of sTNF-R1 was 350 ± 388; 294.7 ± 204.7; 209.5 ± 105.9 pg/ml in active, inactive and control subjects, respectively. There were significantly higher serum levels of these cytokines in active patients than in control subjects (for sIL-2R P = 0.05, CI95% 0.4–331; and sTNF-R1 P = 0.031, CI95% 15.1–321.5). The interleukin levels did not differ between inactive patients and controls. Elevation of IL-15, sIL2-R and sTNF-R1 in active patients provides preliminary evidence for the activation of inflammatory response during PM/DM flares. Further studies may be needed to explain the mechanisms driving these diseases.
- 4 December 2010
- Published by Springer Nature in Rheumatology International
- Vol. 32 (3) , 639-643
Open AccessSerum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity
Cytokines are implied in polymyositis/dermatomyositis (PM/DM) pathogenesis. Our aim was to evaluate the serum levels of interleukin-15 (IL-15), soluble receptors for IL-2 (sIL-2R) and TNF-alpha type 1 receptor (sTNF-R1) in PM/DM patients and their relation to disease activity and clinical symptoms. Thirty-eight patients who met definite or probable criteria of Bohan and Peter for DM/PM were included into the study. Results in patients with active (41 observations) and inactive disease (24 observations) were compared with control (15 subjects). The median level of IL-15 was 47.6 ± 170 pg/ml in active patients, 25.15 ± 240 pg/ml in inactive and 28.5 ± 28.89 pg/ml in controls. We demonstrated significant differences between active patients and controls in levels of IL-15 (0.016, 95%CI 1.39–57.1). The median level of sIL-2R was 314 ± 388, 235.3 ± 269 and 144.3 ± 152.9 pg/ml, and the median level of sTNF-R1 was 350 ± 388; 294.7 ± 204.7; 209.5 ± 105.9 pg/ml in active, inactive and control subjects, respectively. There were significantly higher serum levels of these cytokines in active patients than in control subjects (for sIL-2R P = 0.05, CI95% 0.4–331; and sTNF-R1 P = 0.031, CI95% 15.1–321.5). The interleukin levels did not differ between inactive patients and controls. Elevation of IL-15, sIL2-R and sTNF-R1 in active patients provides preliminary evidence for the activation of inflammatory response during PM/DM flares. Further studies may be needed to explain the mechanisms driving these diseases.